Researchers at the Duke Cancer Institute in Durham, North Carolina have unveiled a new study indicating that slightly higher radiation doses for early stage prostate cancer "may reduce treatment time without compromising effectiveness." The study consist of 1,100 men with early stage prostate cancer; half of the patients received a traditional radiotherapy regiment over 8 weeks, while half received slightly higher doses over 5.5 weeks. According to lead investigator Dr. W. Robert Lee, "the shorter regimen has advantages such as greater patient convenience and lower costs", as indicated over a 5-year period. (an 86% vs. 85% cancer-free survival rate)
To read more about this study, click here.
No comments:
Post a Comment